Observational studyFrontiers in immunology2026
Comparative efficacy of ripertamab, rituximab, and efgartigimod in chronic inflammatory demyelinating polyneuropathy: an exploratory real-world multicenter cohort study.
Yutong Wu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.